{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T14:47:01Z","timestamp":1790434021210,"version":"4.1.0"},"reference-count":153,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2021,10,8]],"date-time":"2021-10-08T00:00:00Z","timestamp":1633651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Background: Stroke remains a leading cause of death and disability throughout the world. It is well established that Diabetes Mellitus (DM) is a risk factor for stroke, while other risk factors include dyslipidaemia and hypertension. Given that the global prevalence of diabetes steadily increases, the need for adequate glycaemic control and prevention of DM-related cardiovascular events remains a challenge for the medical community. Therefore, a re-examination of the latest data related to this issue is of particular importance. Objective: This review aims to summarise the latest data on the relationship between DM and stroke, including epidemiology, risk factors, pathogenesis, prevention and biomarkers. Methods: For this purpose, comprehensive research was performed on the platforms PubMed, Google Scholar and EMBASE with a combination of the following keywords: diabetes mellitus, stroke, macrovascular complications, diabetic stroke, cardiovascular disease. Conclusions: Much progress has been made in stroke in people with DM in terms of prevention and early diagnosis. In the field of prevention, the adaptation of the daily habits and the regulation of co-morbidity of individuals play a particularly important role. Simultaneously, the most significant revolution has been brought by the relatively new treatment options that offer protection to the cardiovascular system. Moreover, many prognostic and diagnostic biomarkers have been identified, paving the way for early and accurate diagnoses. However, to date, there are crucial points that remain controversial and need further clarification.<\/jats:p>","DOI":"10.3390\/jcm10194620","type":"journal-article","created":{"date-parts":[[2021,10,10]],"date-time":"2021-10-10T21:23:25Z","timestamp":1633901005000},"page":"4620","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Diabetes, Vascular Aging and Stroke: Old Dogs, New Tricks?"],"prefix":"10.3390","volume":"10","author":[{"given":"Theano","family":"Penlioglou","sequence":"first","affiliation":[{"name":"Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0555-526X","authenticated-orcid":false,"given":"Anca Pantea","family":"Stoian","sequence":"additional","affiliation":[{"name":"Diabetes, Nutrition and Metabolic Diseases Department, \u201cCarol Davila\u201d University of Medicine, 020021 Bucharest, Romania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7320-785X","authenticated-orcid":false,"given":"Nikolaos","family":"Papanas","sequence":"additional","affiliation":[{"name":"Diabetes Centre, Second Department of Internal Medicine, Democritus University of Thrace, 68132 Alexandroupolis, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,8]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/1570161117666190405165151","article-title":"Macrovascular Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Viigimaa","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1570161117666190502103733","article-title":"Microvascular Complications of Type 2 Diabetes Mellitus","volume":"18","author":"Faselis","year":"2020","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1177\/1479164118780808","article-title":"Risk factors for the development of micro-vascular complications of type 2 diabetes in a single-centre cohort of patients","volume":"15","author":"Teliti","year":"2018","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s00125-003-1116-6","article-title":"Mortality from heart disease in a cohort of 23,000 patients with insulin-treated diabetes","volume":"46","author":"Laing","year":"2003","journal-title":"Diabetologia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/HJR.0b013e3280142037","article-title":"Type 2 diabetes mellitus and risk of coronary heart disease: Results of the 10-year follow-up of the PROCAM study","volume":"14","author":"Buyken","year":"2007","journal-title":"Eur. J. Cardiovasc. Prev. Rehabil."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2337\/diacare.25.3.482","article-title":"The Impact of Cardiovascular Disease on Medical Care Costs in Subjects with and without Type 2 Diabetes","volume":"25","author":"Nichols","year":"2002","journal-title":"Diabetes Care"},{"key":"ref_8","first-page":"17","article-title":"Type II diabetes mellitus and cardiovascular risk factors: Current therapeutic approaches","volume":"12","author":"Kalofoutis","year":"2007","journal-title":"Exp. Clin. Cardiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.amjms.2016.01.011","article-title":"Diabetes and Stroke: Epidemiology, Pathophysiology, Pharmaceuticals and Outcomes","volume":"351","author":"Chen","year":"2016","journal-title":"Am. J. Med Sci."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1161\/CIRCRESAHA.116.308398","article-title":"Stroke Risk Factors, Genetics, and Prevention","volume":"120","author":"Boehme","year":"2017","journal-title":"Circ. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1161\/STROKEAHA.108.517441","article-title":"Long Term Postischemic Stroke Mortality in Diabetes: A veteran cohort analysis","volume":"39","author":"Kamalesh","year":"2008","journal-title":"Stroke"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12933-018-0728-6","article-title":"Prevalence of cardiovascular disease in type 2 diabetes: A systematic literature review of scientific evidence from across the world in 2007\u20132017","volume":"17","author":"Einarson","year":"2018","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1161\/01.STR.25.4.808","article-title":"Stroke in patients with diabetes. The Copenhagen Stroke Study","volume":"25","author":"Nakayama","year":"1994","journal-title":"Stroke"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"e3564","DOI":"10.1136\/bmj.e3564","article-title":"Effect of pre-diabetes on future risk of stroke: Meta-analysis","volume":"344","author":"Lee","year":"2012","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0145721715599267","article-title":"Detecting and Managing Diabetes Mellitus and Prediabetes in Patients with Acute Stroke","volume":"41","author":"Liu","year":"2015","journal-title":"Diabetes Educ."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"286","DOI":"10.5853\/jos.2017.00234","article-title":"Stroke Epidemiology in South, East, and South-East Asia: A Review","volume":"19","author":"Venketasubramanian","year":"2017","journal-title":"J. Stroke"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-2007-981470","article-title":"Epidemiology of Complications and Total Treatment Costs from Diagnosis of Type 2 Diabetes in Germany (ROSSO 4)","volume":"115","author":"Martin","year":"2007","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/STROKEAHA.111.641381","article-title":"Duration of Diabetes and Risk of Ischemic Stroke: The Northern Manhattan Study","volume":"43","author":"Banerjee","year":"2012","journal-title":"Stroke"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"S54","DOI":"10.1007\/PL00002940","article-title":"Risk factors for cardiovascular mortality and morbidity: The WHO multinational study of vascular disease in diabetes","volume":"44","author":"Fuller","year":"2001","journal-title":"Diabetologia"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2016.02.004","article-title":"Diabetes mellitus and risk of ischemic stroke in patients with heart failure and no atrial fibrillation","volume":"209","author":"Melgaard","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc06-2363","article-title":"Prospective Study of Type 1 and Type 2 Diabetes and Risk of Stroke Subtypes: The Nurses\u2019 Health Study","volume":"30","author":"Janghorbani","year":"2007","journal-title":"Diabetes Care"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1464-5491.2006.01959.x","article-title":"Type 1 diabetes as a risk factor for stroke in men and women aged 15\u201349: A nationwide study from Sweden","volume":"23","author":"Sundquist","year":"2006","journal-title":"Diabet. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: A systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes","volume":"383","author":"Peters","year":"2014","journal-title":"Lancet"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S2213-8587(14)70248-7","article-title":"Risk of all-cause mortality and vascular events in women versus men with type 1 diabetes: A systematic review and meta-analysis","volume":"3","author":"Huxley","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1794267","DOI":"10.1155\/2019\/1794267","article-title":"Gender Differences and Risk Factors of Recurrent Stroke in Type 2 Diabetic Malaysian Population with History of Stroke: The Observation from Malaysian National Neurology Registry","volume":"2019","author":"Aziz","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.jstrokecerebrovasdis.2017.08.028","article-title":"Sex Differences in Outcomes after Stroke in Patients with Diabetes in Ontario, Canada","volume":"27","author":"Dhamoon","year":"2017","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2591709","DOI":"10.1155\/2019\/2591709","article-title":"Does Body Mass Index and Height Influence the Incident Risk of Ischemic Stroke in Newly Diagnosed Type 2 Diabetes Subjects?","volume":"2019","author":"Duan","year":"2019","journal-title":"J. Diabetes Res."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/STROKEAHA.114.006718","article-title":"Body Mass Index and Stroke Risk Among Patients with Type 2 Diabetes Mellitus","volume":"46","author":"Li","year":"2015","journal-title":"Stroke"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-008-1190-x","article-title":"Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: An observational study in 13,087 patients","volume":"52","author":"Cederholm","year":"2009","journal-title":"Diabetologia"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.2337\/dcS13-2023","article-title":"Obesity Paradox Does Exist","volume":"36","author":"Hainer","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jamacardio.2018.0022","article-title":"Association of Body Mass Index with Lifetime Risk of Cardiovascular Disease and Compression of Morbidity","volume":"3","author":"Khan","year":"2018","journal-title":"JAMA Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ahj.2008.02.014","article-title":"Body mass index and mortality in heart failure: A meta-analysis","volume":"156","author":"Oreopoulos","year":"2008","journal-title":"Am. Heart J."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0140-6736(06)69251-9","article-title":"Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: A systematic review of cohort studies","volume":"368","author":"Montori","year":"2006","journal-title":"Lancet"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ijo.2015.176","article-title":"Association of overweight and obesity with patient mortality after acute myocardial infarction: A meta-analysis of prospective studies","volume":"40","author":"Wang","year":"2016","journal-title":"Int. J. Obes."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5469\/neuroint.2020.00108","article-title":"Obesity and Stroke: Does the Paradox Apply for Stroke?","volume":"16","author":"Lobo","year":"2021","journal-title":"Neurointervention"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.03.008","article-title":"The Obesity Paradox and Survivors of Ischemic Stroke","volume":"24","author":"Wohlfahrt","year":"2015","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1177\/1559827616650415","article-title":"The Obesity Paradox in Type 2 Diabetes and Mortality","volume":"12","author":"Tobias","year":"2016","journal-title":"Am. J. Lifestyle Med."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.pcad.2018.05.005","article-title":"Obesity and the Obesity Paradox in Heart Failure","volume":"61","author":"Horwich","year":"2018","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/jnnp-2014-308664","article-title":"Obesity-stroke paradox and initial neurological severity","volume":"86","author":"Kim","year":"2015","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Olofindayo, J., Peng, H., Liu, Y., Li, H., Zhang, M., Wang, A., and Zhang, Y. (2015). The interactive effect of diabetes and central obesity on stroke: A prospective cohort study of inner Mongolians. BMC Neurol., 15.","DOI":"10.1186\/s12883-015-0328-y"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"140","DOI":"10.4037\/ajcc2017634","article-title":"Obesity Paradox: Comparison of Heart Failure Patients with and without Comorbid Diabetes","volume":"26","author":"Lee","year":"2017","journal-title":"Am. J. Crit. Care"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention for Endpoint reduction in hypertension study (LIFE): A randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"e2282","DOI":"10.1097\/MD.0000000000002282","article-title":"Impact of Diabetes on Stroke Risk and Outcomes: Two nationwide retrospective cohort studies","volume":"94","author":"Liao","year":"2015","journal-title":"Medicine"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"e002411","DOI":"10.1161\/JAHA.115.002411","article-title":"Long-Term Risk of Stroke in Patients with Type 1 and Type 2 Diabetes Following Coronary Artery Bypass Grafting","volume":"4","author":"Holzmann","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0140-6736(10)60834-3","article-title":"Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): A case-control study","volume":"376","author":"Xavier","year":"2010","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.diabet.2016.11.003","article-title":"Long-term risk of stroke in type 2 diabetes patients with diabetic ketoacidosis: A population-based, propensity score-matched, longitudinal follow-up study","volume":"43","author":"Chen","year":"2017","journal-title":"Diabetes Metab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/dom.13456","article-title":"Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes","volume":"20","author":"Harjutsalo","year":"2018","journal-title":"Diabetes Obes. Metab."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e017706","DOI":"10.1136\/bmjopen-2017-017706","article-title":"Interaction of diabetes and smoking on stroke: A population-based cross-sectional survey in China","volume":"8","author":"Lou","year":"2018","journal-title":"BMJ Open"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1161\/CIRCULATIONAHA.115.017926","article-title":"Relation of Smoking with Total Mortality and Cardiovascular Events Among Patients with Diabetes Mellitus: A meta-analysis and systematic review","volume":"132","author":"Pan","year":"2015","journal-title":"Circulation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1007\/s00125-018-4725-9","article-title":"Dose-dependent effect of smoking on risk of coronary heart disease, heart failure and stroke in individuals with type 1 diabetes","volume":"61","author":"Feodoroff","year":"2018","journal-title":"Diabetologia"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"15373","DOI":"10.1038\/s41598-020-72361-4","article-title":"Association of familial history of diabetes or myocardial infarction and stroke with risk of cardiovascular diseases in four German cohorts","volume":"10","author":"Menzel","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e026626","DOI":"10.1136\/bmjopen-2018-026626","article-title":"Pay-for-performance programmes reduce stroke risks in patients with type 2 diabetes: A national cohort study","volume":"9","author":"Chou","year":"2019","journal-title":"BMJ Open"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12933-020-01018-3","article-title":"Retinopathy predicts stroke but not myocardial infarction in type 2 diabetes: The Fremantle Diabetes Study Phase II","volume":"19","author":"Drinkwater","year":"2020","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e006178","DOI":"10.1161\/JAHA.117.006178","article-title":"Association of Persistent, Incident, and Remittent Proteinuria with Stroke Risk in Patients with Diabetes Mellitus or Prediabetes Mellitus","volume":"6","author":"Wang","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"The Emerging Risk Factors Collaboration (2010). Diabetes Mellitus, fasting blood glucose concentration, and risk of vascular disease: A collaborative meta-analysis of 102 prospective studies. Lancet, 375, 2215\u20132222.","DOI":"10.1016\/S0140-6736(10)60484-9"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1177\/0300060516685205","article-title":"Association between patency of the circle of Willis and diabetes mellitus in patients with cerebral ischaemic stroke","volume":"45","author":"Chi","year":"2017","journal-title":"J. Int. Med. Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.1111\/j.1552-6569.2009.00415.x","article-title":"Epidemiology of Intracranial Stenosis","volume":"19","author":"Suri","year":"2009","journal-title":"J. Neuroimaging"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.06.006","article-title":"Intracranial Arterial Stenosis","volume":"23","author":"Carvalho","year":"2014","journal-title":"J. Stroke Cerebrovasc. Dis."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1159\/000106982","article-title":"Risk Factors of Intracranial Cerebral Atherosclerosis among Asymptomatics","volume":"24","author":"Bae","year":"2007","journal-title":"Cerebrovasc. Dis."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1331.2004.00959.x","article-title":"Risk factors for occlusive lesions of intracranial arteries in stroke-free Japanese","volume":"12","author":"Uehara","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000103125","article-title":"Prevalence and Risk Factors of Middle Cerebral Artery Stenosis in Asymptomatic Residents in Rongqi County, Guangdong","volume":"24","author":"Huang","year":"2007","journal-title":"Cerebrovasc. Dis."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1159\/000116303","article-title":"Middle Cerebral Artery Stenosis Increased the Risk of Vascular Disease Mortality among Type 2 Diabetic Patients","volume":"25","author":"Thomas","year":"2008","journal-title":"Cerebrovasc. Dis."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000071119","article-title":"Middle Cerebral Artery Stenosis in Type II Diabetic Chinese Patients Is Associated with Conventional Risk Factors but Not with Polymorphisms of the Renin-Angiotensin System Genes","volume":"16","author":"Thomas","year":"2003","journal-title":"Cerebrovasc. Dis."},{"key":"ref_66","first-page":"823","article-title":"Type-2 diabetes mellitus reduces cortical thickness and decreases oxidative metabolism in sensorimotor regions after stroke","volume":"38","author":"Ferris","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/1479164116675491","article-title":"White matter injury induced by diabetes in acute stroke is clinically relevant: A preliminary study","volume":"14","author":"Yu","year":"2017","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2014.06.008","article-title":"Global brain atrophy but not hippocampal atrophy is related to type 2 diabetes","volume":"344","author":"Wisse","year":"2014","journal-title":"J. Neurol. Sci."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1016\/j.ejrad.2011.04.025","article-title":"Mapping the brain in type II diabetes: Voxel-based morphometry using DARTEL","volume":"81","author":"Chen","year":"2012","journal-title":"Eur. J. Radiol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2337\/dc12-0555","article-title":"Influence of Type 2 Diabetes on Brain Volumes and Changes in Brain Volumes: Results from the Women\u2019s Health Initiative Magnetic Resonance Imaging Studies","volume":"36","author":"Espeland","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"235","DOI":"10.4239\/wjd.v8.i6.235","article-title":"Diabetes mellitus and stroke: A clinical update","volume":"8","author":"Tun","year":"2017","journal-title":"World J. Diabetes"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"7839101","DOI":"10.1155\/2017\/7839101","article-title":"Macrovascular Complications in Patients with Diabetes and Prediabetes","volume":"2017","author":"Huang","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12974-016-0774-5","article-title":"Cerebral ischemic damage in diabetes: An inflammatory perspective","volume":"14","author":"Shukla","year":"2017","journal-title":"J. Neuroinflamm."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1172\/JCI11235","article-title":"Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site","volume":"108","author":"Du","year":"2001","journal-title":"J. Clin. Investig."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.2337\/dc18-0158","article-title":"Adiponectin, Free Fatty Acids, and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Acute Coronary Syndrome","volume":"41","author":"Schrieks","year":"2018","journal-title":"Diabetes Care"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13872","article-title":"Exposure to hypoglycemia and risk of stroke","volume":"1431","author":"Smith","year":"2018","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1172\/JCI23354","article-title":"Insulin resistance reduces arterial prostacyclin synthase and eNOS activities by increasing endothelial fatty acid oxidation","volume":"116","author":"Du","year":"2006","journal-title":"J. Clin. Investig."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/STR.0b013e318284056a","article-title":"Guidelines for the Early Management of Patients with Acute Ischemic Stroke: A guideline for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Jauch","year":"2013","journal-title":"Stroke"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1111\/dom.13000","article-title":"Hypoglycaemia seriousness and weight gain as determinants of cardiovascular disease outcomes among sulfonylurea users","volume":"19","author":"Nunes","year":"2017","journal-title":"Diabetes Obes. Metab."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11883-013-0351-7","article-title":"Hypoglycemia as a Driver of Cardiovascular Risk in Diabetes","volume":"15","author":"Moheet","year":"2013","journal-title":"Curr. Atheroscler. Rep."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000072554","article-title":"European Stroke Initiative Recommendations for Stroke Management\u2014Update 2003","volume":"16","author":"Hacke","year":"2003","journal-title":"Cerebrovasc. Dis."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/S0140-6736(09)60553-5","article-title":"Stress hyperglycaemia","volume":"373","author":"Dungan","year":"2009","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/hs1001.096194","article-title":"Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: A systematic overview","volume":"32","author":"Capes","year":"2001","journal-title":"Stroke"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"576895","DOI":"10.3389\/fneur.2020.576895","article-title":"Effect of Stress Hyperglycemia on Neurological Deficit and Mortality in the Acute Ischemic Stroke People with and without Diabetes","volume":"11","author":"Li","year":"2020","journal-title":"Front. Neurol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/STROKEAHA.117.019081","article-title":"Stress Hyperglycemia and Prognosis of Minor Ischemic Stroke and Transient Ischemic Attack: The CHANCE Study (Clopidogrel in High-Risk Patients with Acute Nondisabling Cerebrovascular Events)","volume":"48","author":"Pan","year":"2017","journal-title":"Stroke"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1161\/STROKEAHA.107.493544","article-title":"Treatment of Hyperglycemia in Ischemic Stroke (THIS)","volume":"39","author":"Bruno","year":"2008","journal-title":"Stroke"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1161\/STROKEAHA.109.561498","article-title":"Glucose Regulation in Acute Stroke Patients (GRASP) Trial: A randomized pilot trial","volume":"40","author":"Johnston","year":"2009","journal-title":"Stroke"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1474-4422(07)70080-7","article-title":"Glucose-potassium-insulin infusions in the management of post-stroke hyperglycaemia: The UK Glucose Insulin in Stroke Trial (GIST-UK)","volume":"6","author":"Gray","year":"2007","journal-title":"Lancet Neurol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1001\/jama.2019.9346","article-title":"Intensive vs Standard Treatment of Hyperglycemia and Functional Outcome in Patients with Acute Ischemic Stroke: The SHINE randomized clinical trial","volume":"322","author":"Johnston","year":"2019","journal-title":"JAMA"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2174\/1570161114666161208150642","article-title":"Oral Glucose-lowering Drugs and Cardiovascular Outcomes: From the Negative RECORD and ACCORD to Neutral TECOS and Promising EMPA-REG","volume":"15","author":"Tsioufis","year":"2017","journal-title":"Curr. Vasc. Pharmacol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.hjc.2018.11.008","article-title":"GLP-1 receptor agonists and cardiovascular outcome trials: An update","volume":"60","author":"Andrikou","year":"2019","journal-title":"Hell. J. Cardiol."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): A double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(19)30423-1","article-title":"The effect of dulaglutide on stroke: An exploratory analysis of the REWIND trial","volume":"8","author":"Gerstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabet.2018.12.001","article-title":"Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1\u20137 trials","volume":"45","author":"Aroda","year":"2019","journal-title":"Diabetes Metab."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): A double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1111\/dom.14054","article-title":"Efficacy, safety and cardiovascular outcomes of once-daily oral semaglutide in patients with type 2 diabetes: The PIONEER programme","volume":"22","author":"Thethi","year":"2020","journal-title":"Diabetes Obes. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: A meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1161\/STROKEAHA.119.027557","article-title":"Glucagon-Like Peptide-1 Receptor Agonists and Prevention of Stroke Systematic Review of Cardiovascular Outcome Trials with Meta-Analysis","volume":"51","author":"Bellastella","year":"2020","journal-title":"Stroke"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the Effects of Glucagon-Like Peptide Receptor Agonists and Sodium-Glucose Cotransporter 2 Inhibitors for Prevention of Major Adverse Cardiovascular and Renal Outcomes in Type 2 Diabetes Mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00125-019-05039-w","article-title":"2019 update to: Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"63","author":"Buse","year":"2020","journal-title":"Diabetologia"},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12933-021-01258-x","article-title":"Cardiorenal and other diabetes related outcomes with SGLT-2 inhibitors compared to GLP-1 receptor agonists in type 2 diabetes: Nationwide observational study","volume":"20","author":"Lugner","year":"2021","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ahj.2015.07.006","article-title":"Efficacy and safety of rivaroxaban in patients with diabetes and nonvalvular atrial fibrillation: The Rivaroxaban Once-daily, Oral, Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET AF Trial)","volume":"170","author":"Bansilal","year":"2015","journal-title":"Am. Heart J."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"e2876","DOI":"10.1002\/dmrr.2876","article-title":"Safety and efficacy of nonvitamin K antagonist oral anticoagulants versus warfarin in diabetic patients with atrial fibrillation: A study-level meta-analysis of phase III randomized trials","volume":"33","author":"Patti","year":"2017","journal-title":"Diabetes\/Metabolism Res. Rev."},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"American Diabetes Association 8 (2016). Cardiovascular Disease and Risk Management. Diabetes Care, 39, S60\u2013S71.","DOI":"10.2337\/dc16-S011"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.2337\/dc12-2258","article-title":"The Prevalence of Meeting A1C, Blood Pressure, and LDL Goals Among People with Diabetes, 1988\u20132010","volume":"36","author":"Casagrande","year":"2013","journal-title":"Diabetes Care"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.1589","article-title":"For the majority of patients with diabetes blood pressure and lipid management is not in line with recommendations. Results from a large population-based cohort in Germany","volume":"17","author":"Raum","year":"2008","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1475-2840-11-50","article-title":"Blood pressure and lipid management fall far short in persons with type 2 diabetes: Results from the DIAB-CORE Consortium including six German population-based studies","volume":"11","author":"Schunk","year":"2012","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s11892-017-0828-9","article-title":"Medical Management of Diabesity: Do We Have Realistic Targets?","volume":"17","author":"Pappachan","year":"2017","journal-title":"Curr. Diabetes Rep."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric Surgery and Long-term Cardiovascular Events","volume":"307","author":"Peltonen","year":"2012","journal-title":"JAMA"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"e032240","DOI":"10.1136\/bmjopen-2019-032240","article-title":"Association of magnesium intake with type 2 diabetes and total stroke: An updated systematic review and meta-analysis","volume":"10","author":"Zhao","year":"2020","journal-title":"BMJ Open"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"e007858","DOI":"10.1161\/JAHA.117.007858","article-title":"Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis","volume":"7","author":"Mitsios","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"The Diabetes Control and Complications Trial (DCCT)\/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group (2016). Intensive Diabetes Treatment and Cardiovascular Outcomes in Type 1 Diabetes: The DCCT\/EDIC Study 30-Year Follow-up. Diabetes Care, 39, 686\u2013693.","DOI":"10.2337\/dc15-1990"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes","volume":"348","author":"Vedel","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"542","DOI":"10.7326\/M15-3016","article-title":"Diagnosis and Management of Diabetes: Synopsis of the 2016 American Diabetes Association Standards of Medical Care in Diabetes","volume":"164","author":"Chamberlain","year":"2016","journal-title":"Ann. Intern. Med."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood Pressure Targets in Subjects with Type 2 Diabetes Mellitus\/Impaired Fasting Glucose: Observations from traditional and bayesian ran-dom-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: A randomised placebo-controlled trial","volume":"361","author":"Collins","year":"2003","journal-title":"Lancet"},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s13300-020-00801-5","article-title":"Aspirin Versus Clopidogrel Monotherapy for the Secondary Prevention of Recurrent Cerebrovascular Attack Following Previous Ischemic Stroke in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis","volume":"11","author":"Qin","year":"2020","journal-title":"Diabetes Ther."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12933-019-0874-5","article-title":"Effect of pioglitazone in acute ischemic stroke patients with diabetes mellitus: A nested case\u2013control study","volume":"18","author":"Woo","year":"2019","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/CIRCULATIONAHA.116.024863","article-title":"Cardiac Outcomes after Ischemic Stroke or Transient Ischemic Attack: Effects of pioglitazone in patients with insulin resistance without diabetes mellitus","volume":"135","author":"Young","year":"2017","journal-title":"Circulation"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1161\/CIRCULATIONAHA.117.030458","article-title":"Pioglitazone Prevents Stroke in Patients with a Recent Transient Ischemic Attack or Ischemic Stroke: A planned sec-ondary analysis of the iris trial (insulin resistance intervention after stroke)","volume":"137","author":"Yaghi","year":"2018","journal-title":"Circulation"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/STROKEAHA.116.013977","article-title":"Pioglitazone for Secondary Stroke Prevention: A systematic review and meta-analysis","volume":"48","author":"Lee","year":"2017","journal-title":"Stroke"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1016\/j.wneu.2018.08.032","article-title":"Clinical Outcome after Mechanical Thrombectomy in Patients with Diabetes with Major Ischemic Stroke of the Anterior Circulation","volume":"120","author":"Borggrefe","year":"2018","journal-title":"World Neurosurg."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2337\/dc21-0271","article-title":"Prestroke Glucose Control and Functional Outcome in Patients with Acute Large Vessel Occlusive Stroke and Diabetes after Thrombectomy","volume":"44","author":"Chang","year":"2021","journal-title":"Diabetes Care"},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1097\/CM9.0000000000001005","article-title":"Prognostic value of admission hyperglycemia on outcomes of thrombolysis in ischemic stroke patients with or without diabetes","volume":"133","author":"Fang","year":"2020","journal-title":"Chin. Med. J."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1161\/STROKEAHA.111.000813","article-title":"Diabetes Mellitus, Admission Glucose, and Outcomes after Stroke Thrombolysis: A registry and systematic review","volume":"44","author":"Desilles","year":"2013","journal-title":"Stroke"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Papachristou, S., Pafili, K., and Papanas, N. (2021). Skin AGEs and diabetic neuropathy. BMC Endocr. Disord., 21.","DOI":"10.1186\/s12902-021-00697-7"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4196\/kjpp.2014.18.1.1","article-title":"Advanced Glycation End Products and Diabetic Complications","volume":"18","author":"Singh","year":"2014","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s12933-015-0292-2","article-title":"Soluble RAGE and atherosclerosis in youth with type 1 diabetes: A 5-year follow-up study","volume":"14","author":"Heier","year":"2015","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0021-9150(02)00429-X","article-title":"A polymorphism in the promoter of the tumor necrosis factor-\u03b1 gene (\u2212308) is associated with coronary heart disease in type 2 diabetic patients","volume":"167","author":"Vendrell","year":"2003","journal-title":"Atherosclerosis"},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0021-9150(99)00463-3","article-title":"Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link?","volume":"148","author":"Yudkin","year":"2000","journal-title":"Atherosclerosis"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1089\/jir.2014.0212","article-title":"The Protective Effect of Interleukin-37 on Vascular Calcification and Atherosclerosis in Apolipoprotein E-Deficient Mice with Diabetes","volume":"35","author":"Chai","year":"2015","journal-title":"J. Interf. Cytokine Res."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jdiacomp.2005.06.005","article-title":"Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients","volume":"20","author":"Chaturvedi","year":"2006","journal-title":"J. Diabetes Complicat."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0953-6205(02)00014-6","article-title":"Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus","volume":"13","author":"Jude","year":"2002","journal-title":"Eur. J. Intern. Med."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1479164119892223","DOI":"10.1177\/1479164119892223","article-title":"Perfluoroalkyl substances and likelihood of stroke in persons with and without diabetes","volume":"17","author":"Hutcheson","year":"2020","journal-title":"Diabetes Vasc. Dis. Res."},{"key":"ref_143","doi-asserted-by":"crossref","unstructured":"Lee, S.-J., Hong, J.M., Lee, S.E., Kang, D.R., Ovbiagele, B., Demchuk, A.M., and Lee, J.S. (2017). Association of fibrinogen level with early neurological deterioration among acute ischemic stroke patients with diabetes. BMC Neurol., 17.","DOI":"10.1186\/s12883-017-0865-7"},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Sheikhbahaei, S., Manizheh, D., Mohammad, S., Hasan, T.M., Saman, N., Laleh, R., Mahsa, M., Sanaz, A.K., and Shaghayegh, H.J. (2019). Can MiR-503 be used as a marker in diabetic patients with ischemic stroke?. BMC Endocr. Disord., 19.","DOI":"10.1186\/s12902-019-0371-6"},{"key":"ref_145","first-page":"5991","article-title":"Fatty Acid-Binding Protein 4 and Risk of Type 2 Diabetes, Myocardial Infarction and Stroke: A Prospective Cohort Study","volume":"104","author":"Aleksandrova","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.2337\/dc19-0048","article-title":"Utility of Plasma Concentration of Trimethylamine N-Oxide in Predicting Cardiovascular and Renal Complications in Individuals with Type 1 Diabetes","volume":"42","author":"Winther","year":"2019","journal-title":"Diabetes Care"},{"key":"ref_147","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature"},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat. Med."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1161\/STROKEAHA.119.024941","article-title":"Serum NfL (Neurofilament Light Chain) Levels and Incident Stroke in Adults with Diabetes Mellitus","volume":"50","author":"Korley","year":"2019","journal-title":"Stroke"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1586\/14737175.2015.1030734","article-title":"Prognostic value of copeptin in patients with acute stroke","volume":"15","author":"Jiao","year":"2015","journal-title":"Expert Rev. Neurother."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/ana.21783","article-title":"Copeptin: A novel, independent prognostic marker in patients with ischemic stroke","volume":"66","author":"Katan","year":"2009","journal-title":"Ann. Neurol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1016\/j.jdiacomp.2016.07.030","article-title":"Plasma copeptin and functional outcome in patients with ischemic stroke and type 2 diabetes","volume":"30","author":"Wang","year":"2016","journal-title":"J. Diabetes Complicat."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1159\/000481626","article-title":"Serum 1,5-Anhydroglucitol: Risk Factor of Acute Ischemic Stroke and Transient Ischemic Attack in Well-Controlled Diabetes","volume":"44","author":"Shiga","year":"2017","journal-title":"Cerebrovasc. Dis."}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/19\/4620\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:10:28Z","timestamp":1760166628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/10\/19\/4620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,8]]},"references-count":153,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["jcm10194620"],"URL":"https:\/\/doi.org\/10.3390\/jcm10194620","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,8]]}}}